The skeletal dysplasias

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 16, Issue 3, 2002, Pages 547-560

  Savarirayan, Ravi ^a   Rimoin, David L ^b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Bone disease; Developmental; Osteochondrodysplasias

Indexed keywords

HUMAN GROWTH HORMONE;

ACHONDROPLASIA; ANAMNESIS; BONE DEVELOPMENT; BONE DYSPLASIA; BONE GROWTH; CHONDRODYSPLASIA; DECOMPRESSION SURGERY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; FAMILY HISTORY; GENETIC DISORDER; GENOTYPE; HEALTH EDUCATION; HUMAN; HYDROCEPHALUS; KYPHOSIS; LEG LENGTHENING; MALOCCLUSION; MEDICAL ASSESSMENT; MEDICAL DOCUMENTATION; MEDICAL PROFESSION; NOSE OBSTRUCTION; PHENOTYPE; PHYSICAL EXAMINATION; PRENATAL DIAGNOSIS; RADIOGRAPHY; REVIEW; SHORT STATURE; SOCIAL SUPPORT; VERTEBRAL CANAL STENOSIS; BONE RADIOGRAPHY; BONE TISSUE; EMBRYOLOGY; HISTOPATHOLOGY; PATHOGENESIS;

EID: 0036428466     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1053/beem.2002.0210     Document Type: Article

References (39)

1. Rosenberg A. Bones, joints and soft tissue tumours. In Cotran RS, Kumar V & Collins T (eds) Robbins Pathologic Basis of Disease, 6th edn, pp 1215-1221. Philadelphia: WB Saunders Co, 1999.
2. Karsenty G. Genetics of skeletogenesis. Developmental Genetics 1998; 22: 301-313.
3. Dreyer SD, Zhou G & Lee B. The long and the short of it: developmental genetics of the skeletal dysplasias. Clinical Genetics 1998; 54: 464-473.
4. International Working Group on Constitutional Diseases of Bone. International Nomenclature and Classification of the Osteochondrodysplasias (1997). American Journal of Medical Genetics 1998; 79: 376-382.
5. Sharony R, Browne C, Lachman RS & Rimoin DL. Prenatal diagnosis of the skeletal dysplasias. American Journal of Obstetrics and Gynecology 1993; 169: 668-675.
6. Orioli IM, Castilla EE, Scarano G & Mastroiacovo P. Effect of paternal age in achondroplasia, thanatophoric dysplasia, and osteogenesis imperfecta. American Journal of Medical Genetics 1995; 59: 209-217.
7. Rimoin DL, Lachman R & Unger S. Chondrodysplasias. In Rimoin DL, Connor JM, Peyritz R & Korf B (eds) Emery and Rimoin's Principles and Practice of Medical Genetics, 4th edn, pp 4071-4115. Edinburgh: Churchill-Livingstone, 2002.
8. Hall JG, Froster-Iskenius UG & Allanson JE. Handbook of Normal Physical Measurements. New York: Oxford University Press, 1995.
9. McKusick VA, Egeland JA, Eldridge R & Krusen DR. Dwarfism in the Amish I. The Ellis-van Creveld syndrome. Bulletin of John Hopkins Hospital 1964; 115: 305-336.
10. Franceschini P, Guala A, Vardeu MP et al. Short rib-dysplasia group (with/without polydactyly): report of a patient suggesting the existence of a continuous spectrum. American Journal of Medical Genetics 1995; 59: 359-364.
11. Toledo SP, Saldanha PH, Lamego C et al. Dyggve-Melchior-Clausen syndrome: genetic studies and report of affected sibs. American Journal of Medical Genetics 1979; 4: 255-261.
12. McKeand J, Rotta J & Hecht JT. Natural history study of pseudoachondroplasia. American Journal of Medical Genetics 1996; 63: 406-410.
13. Carter AR & Currey HL. Dyschondrosteosis (mesomelic dwarfism): a family study. British Journal of Radiology 1974; 47: 634-640.
14. Ruiz-Perez VL, Ide SE, Strom TM et al. Mutations in a new gene in Ellis-van Creveld syndrome and Weyers acrodental dysostosis. Nature Genetics 2000; 24: 283-286.
15. Goldblatt J, Wallis C, Viljoen D & Beighton P. Heterozygous manifestations of Langer mesomelic dysplasia. Clinical Genetics 1987; 31: 19-24.
16. Taybi H & Lachman RS. Radiology of Syndromes, Metabolic Disorders, and Skeletal Dysplasias, 4th edn. St Louis: Mosby-Year Book, 1996.
17. Ornoy A, Borochowitz Z, Lachman R & Rimoin DL. Atlas of Fetal Skeletal Radiology. Chicago: Year Book Medical Publishers, 1988.
18. Savarirayan R & Bankier A. Acampomelic campomelic dysplasia with de novo 5q;17q reciprocal translocation and severe phenotype. Journal of Medical Genetics 1998; 35: 597-599.
19. Rimoin DL & Krakow D. Skeletal dysplasias. In New M (ed.) Diagnosis and Treatment of the Unborn Child, pp 63-65. Reddick, FL: Idelson-Gnocchi, 1999.
20. Makrydimas G, Souka A, Skentou H et al. Osteogenesis imperfecta and other skeletal dysplasias presenting with increased nuchal translucency in the first trimester. American Journal of Medical Genetics 2001; 98: 117-120.
21. Pattarelli P, Pretorious DH & Edwards DK. Intrauterine growth retardation mimicking skeletal dysplasia on antenatal ultrasound. Journal of Ultrasound Medicine 1990; 12: 737-739.
22. Ramus RM, Martin LB & Twickler DM. Ultrasonographic prediction of fetal outcome in suspected skeletal dysplasias with use of the femur length-to-abdominal circumference ratio. Journal of Obstetrics and Gynecology 1998; 179: 1348-1352.
23. Hersh JH, Angle B, Pietrantoni M et al. Predictive value of fetal ultrasonography in the diagnosis of a lethal skeletal dysplasia. Southern Medical Journal 1998; 12: 1137-1142.
24. Rimoin DL. The chondrodystrophies. Advances in Human Genetics 1975; 5: 1-118.
25. Sillence DO, Horton WA & Rimoin DL. Morphologic studies in the skeletal dysplasias. American Journal of Pathology 1979; 96: 811-870.
26. Eteson DJ, Adomian GE, Ornoy A et al. Fibrochondrogenesis: radiologic and histologic studies. American Journal of Medical Genetics 1984; 19: 277-290.
27. Savarirayan R, Cormier-Daire V, Unger S. et al. Oto-palato-digital syndrome, type II: report of three cases with further delineation of the chondro-osseous morphology. American Journal of Medical Genetics 2000; 95: 193-200.
28. Vranka J, Mokashi A, Keene DR et al. Selective intracellular retention of extracellular matrix proteins and chaperones associated with pseudoachondroplasia. Matrix Biology 2001; 20: 439-450.
29. Superti-Furga A, Hastbacka J, Wilcox WR et al. Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter gene. Nature Genetics 1996; 12: 100-102.
30. Karniski P. Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene: correlation between sulfate transport activity and chondrodysplasia phenotype. Human Molecular Genetics 2001; 10: 1485-1490.
31. Rimoin DL. Molecular defects in the chondrodyplasias. American Journal of Medical Genetics 1996; 63: 106-110.
32. Hunter AG, Bankier A, Rogers JG et al. Medical complications of achondroplasia: a multicentre patient review. Journal of Medical Genetics 1998; 35: 705-712.
33. Horton WA, Rotter JI, Rimoin DL et al. Standard growth curves for achondroplasia. Journal of Pediatrics 1978; 93: 435-438.
34. Hunter AG, Hecht JT & Scott CI Jr. Standard weight for height curves in achondroplasia. American Journal of Medical Genetics 1996; 62: 255-261.
35. Kanaka-Gantenbein C. Present status of the use of growth hormone in short children with bone diseases (diseases of the skeleton). Journal of Pediatric Endocrinology and Metabolism 2001; 14: 17-26.
36. Yasui N, Kawabata H, Kojimoto H. et al. Lengthening of the lower limbs in patients with achondroplasia and hypochondroplasia. Clinical Orthopedics 1997; 344: 298-306.
37. Gordon N. The neurological complications of achondroplasia. Brain Development 2000; 22; 3-7.
38. Hecht JT, Hood OJ, Schwartz RJ et al. Obesity in achondroplasia. American Journal of Medical Genetics 1988; 31: 597-602.
39. Health supervision for children with achondroplasia. American Academy of Pediatrics Committtee on Genetics. Pediatrics 1995; 95: 443-451.